Technology Agreement Account FormTechnology Services Agreement • September 11th, 2018 • Glucose Biosensor Systems (Greater China) Holdings, Inc. • Surgical & medical instruments & apparatus • New York
This TECHNOLOGY SERVICES AGREEMENT, which consists of this account form (the “Account Form”) and the associated Terms and Conditions (the “Terms and Conditions”) attached hereto as Exhibit A, is made and entered into as of %%TODAY%% (the “Effective Date”) between %%ISSUER_NAME%% (collectively referred to as “Issuer”, “you”, “your”) for its offering of securities entitled <offering name> (“Offering”), and FundAmerica, LLC (“FundAmerica”, “Technology Provider,” “we,” “our,” or “us”).
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • September 11th, 2018 • Glucose Biosensor Systems (Greater China) Holdings, Inc. • Surgical & medical instruments & apparatus • New York
SCHEDULE 1 – PARTIES TO MSA 4 SCHEDULE 2 – GENERAL TERMS AND CONDITIONS 5Master Services Agreement • September 11th, 2018 • Glucose Biosensor Systems (Greater China) Holdings, Inc. • Surgical & medical instruments & apparatus
to all other parties at either the postal address, facsimile number or email address specified for the parties at Schedule 1.
SUBSCRIPTION AGREEMENTSubscription Agreement • September 11th, 2018 • Glucose Biosensor Systems (Greater China) Holdings, Inc. • Surgical & medical instruments & apparatus • New York
THIS INVESTMENT INVOLVES A HIGH DEGREE OF RISK. THIS INVESTMENT IS SUITABLE ONLY FOR PERSONS WHO CAN BEAR THE ECONOMIC RISK FOR AN INDEFINITE PERIOD OF TIME AND WHO CAN AFFORD TO LOSE THEIR ENTIRE INVESTMENT. FURTHERMORE, INVESTORS MUST UNDERSTAND THAT THE MARKET FOR SUCH INVESTMENT MAY BE LIMITED AND SPORADIC AND IS EXPECTED TO CONTINUE TO BE LIMITED AND SPORADIC FOR AN INDEFINITE PERIOD OF TIME. NO PUBLIC MARKET CURRENTLY EXISTS FOR THE SECURITIES.
VARIATION AGREEMENT TO TECHNOLOGY LICENCE AGREEMENTVariation Agreement • September 11th, 2018 • Glucose Biosensor Systems (Greater China) Holdings, Inc. • Surgical & medical instruments & apparatus
This Variation Agreement to the Technology License Agreement (this “Variation Agreement”) dated as 8 December 2017 (the “Effective Date”), is by and between Life Science Biosensor Diagnostics Pty Ltd., an Australian proprietary limited company having an address at Level 7, 222 Clarence Street, Sydney NSW 2000 Australia (“Licensor”) and Glucose Biosensor Systems (Greater China) Holdings Inc., a company having an registered office at Corporation Trust Centre, 1209 Orange St, City of Wilmington, County of New Castle, Delaware 19801 (“Licensee”) (each, a “Party” and collectively the “Parties”).
